Skip to main content

  • Evolut R Improved on Some Earlier Gen Outcomes But paravalvular regurgitation and pacemaker rates are still a problem

    • Posted: 02/07/2017
    • Author:

      Nicole Lou Reporter, MedPage Today/CRTonline.org

    The CoreValve Evolut R improved upon the complication rate of earlier transcatheter heart valves, according to two observational studies.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details